Here, we provide evidence from both in vitro and in vivo experiments, employing a wide range of GC cell lines, patient-derived tumor organoids (PDOs) as well as CDX and PDX xenograft models, to demonstrate that BCLXL and MCL1 are key for GC cell survival. This evidence concerns the gene BCL2L1 and neoplasm.